Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Gimenez-Capitan

Differential Effect of MMSET mRNA Levels on Survival to First-Line FOLFOX and Second-Line Docetaxel in Gastric Cancer

British Journal of Cancer

Cancer Research

Oncology

2014

English

Related publications

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine Plus Docetaxel in Non-Small-Cell Lung Cancer Patients

PLoS ONE

Multidisciplinary

2008

English

The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer

Clinical Genitourinary Cancer

Oncology

Urology

2015

English

Comparative Analysis of the Efficacy and Safety of Modified FOLFOX-6 and DCF Regimens as First-Line Treatment in Advanced Gastric Cancer

Molecular and Clinical Oncology

Cancer Research

Oncology

2015

English

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

English

A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases

English

Combined Effect of Sodium Selenite and Docetaxel on PC3 Metastatic Prostate Cancer Cell Line

Biochemical and Biophysical Research Communications

English

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Pathology and Oncology Research

English

Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2015

English

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A Gimenez-Capitan

Differential Effect of MMSET mRNA Levels on Survival to First-Line FOLFOX and Second-Line Docetaxel in Gastric Cancer

Related publications

Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine Plus Docetaxel in Non-Small-Cell Lung Cancer Patients

The Effect of Therapeutic Anticoagulation on Overall Survival in Men Receiving First-Line Docetaxel Chemotherapy for Metastatic Castration-Resistant Prostate Cancer

Comparative Analysis of the Efficacy and Safety of Modified FOLFOX-6 and DCF Regimens as First-Line Treatment in Advanced Gastric Cancer

Oxaliplatin, 5-Fluorouracil and Leucovorin (Modified FOLFOX-6) as First-Line Chemotherapy for Advanced Gastric Cancer Patients With Poor Performance Status

A Phase II Study of Modified FOLFOX as First-Line Chemotherapy for Metastatic Gastric Cancer in Elderly Patients With Associated Diseases

Combined Effect of Sodium Selenite and Docetaxel on PC3 Metastatic Prostate Cancer Cell Line

Survival Benefits of Second-Line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma

Second-Line Treatment of Advanced Gastric Cancer: Where Do We Stand?

FOLFOX as Second-Line Chemotherapy in Patients With Pretreated Metastatic Pancreatic Cancer From the FIRGEM Study